Menu
×
West Ashley Library
Closed
Phone: (843) 766-6635
Wando Mount Pleasant Library
Closed
Phone: (843) 805-6888
Village Library
Closed
Phone: (843) 884-9741
St. Paul's/Hollywood Library
Closed
Phone: (843) 889-3300
Otranto Road Library
Closed
Phone: (843) 572-4094
Mt. Pleasant Library
Closed
Phone: (843) 849-6161
McClellanville Library
Closed
Phone: (843) 887-3699
Keith Summey North Charleston Library
Closed
Phone: (843) 744-2489
John's Island Library
Closed
Phone: (843) 559-1945
Hurd/St. Andrews Library
Closed
Phone: (843) 766-2546
Folly Beach Library
Closed
Phone: (843) 588-2001
Dorchester Road Library
Closed
Phone: (843) 552-6466
John L. Dart Library
Closed
Phone: (843) 722-7550
Bees Ferry West Ashley Library
Closed
Phone: (843) 805-6892
Baxter-Patrick James Island
Closed
Phone: (843) 795-6679
Miss Jane's Building (Edisto Library Temporary Location)
Closed
Phone: (843) 869-2355
Edgar Allan Poe/Sullivan's Island Library
Closed for renovations
Phone: (843) 883-3914
Main Library
2 p.m. – 5 p.m.
Phone: (843) 805-6930
Mobile Library
Closed
Phone: (843) 805-6909
Today's Hours
West Ashley Library
Closed
Phone: (843) 766-6635
Wando Mount Pleasant Library
Closed
Phone: (843) 805-6888
Village Library
Closed
Phone: (843) 884-9741
St. Paul's/Hollywood Library
Closed
Phone: (843) 889-3300
Otranto Road Library
Closed
Phone: (843) 572-4094
Mt. Pleasant Library
Closed
Phone: (843) 849-6161
McClellanville Library
Closed
Phone: (843) 887-3699
Keith Summey North Charleston Library
Closed
Phone: (843) 744-2489
John's Island Library
Closed
Phone: (843) 559-1945
Hurd/St. Andrews Library
Closed
Phone: (843) 766-2546
Folly Beach Library
Closed
Phone: (843) 588-2001
Dorchester Road Library
Closed
Phone: (843) 552-6466
John L. Dart Library
Closed
Phone: (843) 722-7550
Bees Ferry West Ashley Library
Closed
Phone: (843) 805-6892
Baxter-Patrick James Island
Closed
Phone: (843) 795-6679
Miss Jane's Building (Edisto Library Temporary Location)
Closed
Phone: (843) 869-2355
Edgar Allan Poe/Sullivan's Island Library
Closed for renovations
Phone: (843) 883-3914
Main Library
2 p.m. – 5 p.m.
Phone: (843) 805-6930
Mobile Library
Closed
Phone: (843) 805-6909
Patron Login
menu
Item request has been placed!
×
Item request cannot be made.
×
Processing Request
Continuation phase treatment outcomes for switching, combining, or augmenting strategies for treatment‐resistant major depressive disorder: A VAST‐D report.
Item request has been placed!
×
Item request cannot be made.
×
Processing Request
- Author(s): Zisook, Sidney (AUTHOR); Johnson, Gary R. (AUTHOR); Hicks, Paul (AUTHOR); Chen, Peijun (AUTHOR); Beresford, Thomas (AUTHOR); Michalets, James P. (AUTHOR); Rao, Sanjai (AUTHOR); Thase, Michael E. (AUTHOR); Wilcox, James (AUTHOR); Sevilimedu, Varadan (AUTHOR); Mohamed, Somaia (AUTHOR)
- Source:
Depression & Anxiety (1091-4269). Feb2021, Vol. 38 Issue 2, p185-195. 11p. 2 Charts, 2 Graphs. - Source:
- Additional Information
- Subject Terms:
- Abstract: Background: This secondary analysis of the VA Augmentation and Switching Treatments for Depression study compared the continuation phase treatment outcomes of three commonly used second‐step treatment strategies following at least one prior failed medication treatment attempt. Methods: In total, 1522 outpatients with MDD were randomized to switching to bupropion‐SR (S‐BUP), combining with bupropion‐SR (C‐BUP), or augmenting with aripiprazole (A‐ARI). Following 12 weeks of acute phase treatment, 725 entered the 24‐week continuation treatment phase. Depressive symptom severity, relapse, "emergent" remission, anxiety, suicidal ideation, quality of life, health status, and side effects were compared. Results: We did not find clinically significant differential treatment effects with the exception that A‐ARI was associated with less anxiety than S‐BUP or C‐BUP. Participants who entered continuation treatment as remitters had milder depressive symptom severity and lower relapse rates than those not in remission; they also experienced more improvement on most other outcomes. A‐ARI was associated with less anxiety, insomnia, and dry mouth but more somnolence, extrapyramidal effects, akathisia, abnormal laboratory values, and appetite and weight gain. Conclusions: Continuation treatment is a dynamic period. Regardless of the treatment, participants who entered continuation treatment at Week 12 in full remission continued to have better outcomes over the subsequent 24 weeks than those who were not in remission at the start of the continuation phase. [ABSTRACT FROM AUTHOR]
- Abstract: Copyright of Depression & Anxiety (1091-4269) is the property of Hindawi Limited and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Contact CCPL
Copyright 2022 Charleston County Public Library Powered By EBSCO Stacks 3.3.0 [350.3] | Staff Login
No Comments.